Page last updated: 2024-12-11

glyceryl behenate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-behenoylglycerol : A fatty acid ester resulting from the formal condensation of the hydroxy group at position-1 of glycerol with the carboxy group of docosanoic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5362585
CHEBI ID142497
SCHEMBL ID3805
MeSH IDM0229060

Synonyms (37)

Synonym
2,3-dihydroxypropyl docosanoate
glyceryl behenate
behenin
1,2,3-propanetriol docosanoate
glycerine monobehenate
glycerol behenate
glycerol-behenic acid monoester
1-behenoylglycerol
CHEBI:142497
1-acylglycerol 22:0
docosanoic acid 2',3'-dihydroxypropyl ester
30233-64-8
1-docosanoylglycerol
1-o-docosanoylglycerol
ec 278-717-5
einecs 278-717-5
docosanoic acid, ester with 1,2,3-propanetriol
77538-19-3
unii-a626uu0w2a
docosanoic acid, monoester with 1,2,3-propanetriol
glyceryl monobehenate
docosanoic acid, 2,3-dihydroxypropyl ester
a626uu0w2a ,
einecs 250-097-0
docosanoic acid, monoester with glycerol
behenic monoglyceride
OKMWKBLSFKFYGZ-UHFFFAOYSA-N
SCHEMBL3805
glyceryl behenate [inci]
6916-74-1
docosanoic acid,2,3-dihydroxypropyl ester
mag 22:0
DTXSID701015809
1-monobehenoylglycerol
glyceryl tribehenate; glyceryl tridocosanoate; lipovol gtb
1-monodocosanoin
Q27273676

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The pharmacokinetic processes of sorafenib solution and lyophilized injection of S-SLN in vivo were in accordance with the two-compartment and one-compartment models, respectively."( Preparation, in vitro release, and pharmacokinetics in rabbits of lyophilized injection of sorafenib solid lipid nanoparticles.
Yan, SJ; Zhang, FM; Zhang, H, 2012
)
0.38
"The intent of this investigation was to improve pharmacokinetic (PK) and pharmacodynamic (PD) effects of Rosuvastatin calcium (RC) by solid lipid nanoparticles (SLNs)."( Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation.
Dudhipala, N; Veerabrahma, K, 2017
)
0.46

Bioavailability

ExcerptReferenceRelevance
" The oral bioavailability of 150 nm SLN was remarkably higher than the other two size SLN."( [Effect of particle size on oral absorption of silymarin-loaded solid lipid nanoparticles].
Cai, BQ; Feng, JF; He, J; Hou, SX, 2005
)
0.33
" The percentage bioavailability was significantly enhanced."( Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting.
Aji Alex, MR; Chacko, AJ; Jose, S; Souto, EB, 2011
)
0.37
"The purpose of the present investigation was to develop solid lipid nanoparticles (SLNs) of simvastatin in order to enhance its oral bioavailability by minimizing its first-pass metabolism."( Oral solid compritol 888 ATO nanosuspension of simvastatin: optimization and biodistribution studies.
Chuttani, K; Mishra, AK; Pathak, K; Shah, M, 2011
)
0.37
"This provided an increase in relative oral bioavailability of 1500% after a single oral administration of drug-loaded LNs, maintaining edelfosine plasma levels over 7 days in contrast to a single oral administration of edelfosine solution, which presented a relative oral bioavailability of 10%."( Complete inhibition of extranodal dissemination of lymphoma by edelfosine-loaded lipid nanoparticles.
Blanco-Prieto, MJ; Campanero, MA; de la Iglesia-Vicente, J; Estella-Hermoso de Mendoza, A; Lana, H; Mollinedo, F; Villa-Pulgarin, JA, 2012
)
0.38
"75 min, respectively, with a significant increase in bioavailability in a rat model compared with a free-drug suspension."( Enhanced delivery of lopinavir to the CNS using Compritol-based solid lipid nanoparticles.
Alex, A; Chacko, AJ; Paul, W; Sharma, CP, 2011
)
0.37
" Manufacturers apply different techniques to mask the bitter taste of these products, depending on the characteristics of the dosage form and the bioavailability requirements."( [Taste-masking possibilities in solid dosage forms].
Szakonyi, G; Zelkó, R, 2012
)
0.38
" Moreover, in vivo bioavailability of LP-MS was evaluated with conventional enteric microspheres (enteric MS) as reference."( Novel pH-sensitive lipid-polymer composite microspheres of 10-hydroxycamptothecin exhibiting colon-specific biodistribution and reduced systemic absorption.
Gan, L; Gan, Y; Gao, YP; Zhang, XX; Zhu, CL, 2013
)
0.39
" The bioavailability of sustained release tablets, F7 was compared with commercially available tablets, MetXL50 in 12 healthy human volunteers in a crossover design."( Compritol®888 ATO a lipid excipient for sustained release of highly water soluble active: formulation, scale-up and IVIVC study.
Desai, NS; Farah, N; Gogtay, N; Jain, AS; Kadam, PP; Kapadia, CJ; Nagarsenker, MS; Patere, SN; Thatte, UM, 2013
)
0.39
"The purpose of this research was to improve oral bioavailability of poorly aqueous soluble drug lopinavir using solid lipid nanoparticles (SLNs)."( Development and evaluation of glyceryl behenate based solid lipid nanoparticles (SLNs) using hot self-nanoemulsification (SNE) technique.
Chattopadhyay, P; Negi, JS; Ram, V; Sharma, AK, 2014
)
0.69
"Raloxifene HCl (RLX) shows low oral bioavailability (<2%) in humans due to poor aqueous solubility and extensive (>90%) metabolism in gut."( Lipid nanoparticles for oral delivery of raloxifene: optimization, stability, in vivo evaluation and uptake mechanism.
Aditya, N; Kathuria, H; Malekar, S; Ravi, PR; Vats, R, 2014
)
0.4
" This study was to investigate the bioavailability of sustained-release solid dispersion (SR-SD) formulation of SGL to sustain the drug release for up to 24 h."( Sustained-release formulation of sarpogrelate hydrochloride.
Kim, HJ; Kim, JS; Lim, EA; Shin, DH, 2015
)
0.42
"The aim of this study is to investigate the potential of nanostructured lipid carriers (NLCs) in improving the oral bioavailability of a lipid lowering agent, fenofibrate (FEN)."( Preparation and characterization of fenofibrate-loaded nanostructured lipid carriers for oral bioavailability enhancement.
Choi, HG; Kim, JO; Ramasamy, T; Tran, TH; Truong, DH; Yong, CS, 2014
)
0.4
" Local use of KTZ loaded nanocarrier system can address its toxicity, poor solubility, photodegradation, permeation and bioavailability issues."( Lipid-polyethylene glycol based nano-ocular formulation of ketoconazole.
Giansanti, F; Kakkar, S; Karuppayil, SM; Kaur, IP; Papucci, L; Raut, JS; Schiavone, N, 2015
)
0.42
"70%) of the EFV reaching to liver indicates that major amount of EFV bypasses the liver and thereby, enhances the oral bioavailability of the EFV."( Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approach.
Jain, R; Joshi, A; Makwana, V; Nivsarkar, M; Patel, K, 2015
)
0.42
" RC is anti-hyperlipidemic drug with low oral bioavailability (20%) due to first-pass metabolism."( Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation.
Dudhipala, N; Veerabrahma, K, 2017
)
0.46
"Associating protein with nanoparticles is an interesting strategy to improve their bioavailability and biological activity."( Microencapsulated SLN: An innovative strategy for pulmonary protein delivery.
Almeida, AJ; Gaspar, DP; Gonçalves, L; Lino, PR; Remuñán-López, C; Serra, C; Taboada, P, 2017
)
0.46
"5%, w/w) exhibited an elevated bioavailability compared to the commercial product, Effexor® XR."( Engineering hot-melt extruded solid dispersion for controlled release of hydrophilic drugs.
Fan, A; Meng, X; Tang, Y; Wang, G; Wang, Z; Zhang, S; Zhao, Y, 2017
)
0.46
"Solid lipid nanoparticles (SLNs) are considered a promising system in enhancing the oral bioavailability of poorly water-soluble drugs; owing to their intrinsic ability to increase the solubility together with protecting the incorporated drugs from extensive metabolism."( Lipid-Based Gliclazide Nanoparticles for Treatment of Diabetes: Formulation, Pharmacokinetics, Pharmacodynamics and Subacute Toxicity Study.
El-Kamel, AH; Hassaan, PS; Khalifa, HM; Nazief, AM; Sokar, MS, 2020
)
0.56
"Exploiting such properties, SLNs loaded with gliclazide (GLZ) were developed in an attempt to improve the oral bioavailability and the anti-diabetic action of GLZ, together with prolonging its duration of action for better glycemic control."( Lipid-Based Gliclazide Nanoparticles for Treatment of Diabetes: Formulation, Pharmacokinetics, Pharmacodynamics and Subacute Toxicity Study.
El-Kamel, AH; Hassaan, PS; Khalifa, HM; Nazief, AM; Sokar, MS, 2020
)
0.56
" However, the drug has reduced bioavailability related to low water solubility and first pass metabolism."( Optimized semisolid self-nanoemulsifying system based on glyceryl behenate: A potential nanoplatform for enhancing antitumor activity of raloxifene hydrochloride in MCF-7 human breast cancer cells.
Ahmed, OAA; Aldawsari, HM; Alhakamy, NA; Badr-Eldin, SM; Fahmy, UA; Neamatallah, T; Okbazghi, SZ, 2021
)
0.87

Dosage Studied

ExcerptRelevanceReference
"Compritol 888 ATO is used as a lubricant in oral solid dosage formulations."( Comparative study of the lubricant performance of Compritol 888 ATO either used by blending or by hot melt coating.
Andrès, C; Bérard, V; Jannin, V; N'Diaye, A; Pourcelot, Y, 2003
)
0.32
"For treatment of allergic rhinitis, acrivastine with pseudoephedrine in Semprex-D conventional capsules requires dosing every 6-8 hours."( Evaluation and comparison of five matrix excipients for the controlled release of acrivastine and pseudoephedrine.
Fediuk, DJ; Gu, X; Simons, FE; Simons, KJ, 2004
)
0.32
" An increase of urinary excretion of riboflavin was observed when the volunteers were dosed with the floating pellets, especially after feeding."( In vitro and in vivo evaluation of floating riboflavin pellets developed using the melt pelletization process.
Amighi, K; Goole, J; Hamdani, J; Moës, AJ, 2006
)
0.33
"CompritolR888 ATO (glycerol behenate) is widely used as a pharmaceutical excipient in the field of solid dosage forms due to its lubricating properties."( Polymorphic behaviour of Compritol888 ATO as bulk lipid and as SLN and NLC.
Mehnert, W; Müller, RH; Souto, EB, 2006
)
0.33
" Lipid granules of KTZ prepared with Compritol 888 ATO could be proposed as a new KTZ solid dosage form with optimum dissolution and therapeutic characteristics."( In vitro release--in vivo microbiological and toxicological studies on ketoconazole lipid granules.
Ay, Z; Durmaz, G; Ertan, G; Gokce, EH; Gokce, G; Guneri, T; Hilmioglu, S; Metin, DY; Ozer, O; Ozyazici, M; Ozyurt, D; Pekcetin, C; Yalcin, A, 2007
)
0.34
" The drug release rate was also strongly dependent on the granulation and compaction process as the coated particles were incorporated into the tablet dosage form."( Simple preparation of coated resin complexes and their incorporation into fast-disintegrating tablets.
Jeong, SH; Park, K, 2010
)
0.36
"This study deals with the development of an oral controlled-release dosage form of a highly water-soluble antiepileptic drug."( Controlled release of a highly hydrophilic API from lipid microspheres obtained by prilling: analysis of drug and water diffusion processes with X-ray-based methods.
Daste, G; Faivre, V; Gueutin, C; Lesieur, S; Mancini, L; Ollivon, M; Pivette, P, 2012
)
0.38
"Sustained-release mini-tablets are a potentially suitable for paediatric drug delivery or as multi-particulate dosage forms."( Development and evaluation of sustained-release Compritol® 888 ATO matrix mini-tablets.
Marchaud, D; Miolane, C; Mostafa, S; Roberts, M; Vellucci, D, 2012
)
0.38
"Tailored drug release from matrix mini-tablets may achieved by altering the size of mini-tablet or level of Compritol® 888 ATO in the formulation and this may have potential in the development of paediatric formulations or multi-particulate dosage forms."( Development and evaluation of sustained-release Compritol® 888 ATO matrix mini-tablets.
Marchaud, D; Miolane, C; Mostafa, S; Roberts, M; Vellucci, D, 2012
)
0.38
" One of the important dosage forms is the group of orally disintegrating products."( [Taste-masking possibilities in solid dosage forms].
Szakonyi, G; Zelkó, R, 2012
)
0.38
" Therefore, the developed sustained-release tablet formulation of TOL could be an alternative dosage form to the SR capsule for treatment of OAB."( Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate.
Chang, SW; Kim, JO; Kim, YI; Pradhan, R, 2014
)
0.4
"Different researches have highlighted the feasibility of using Compritol 888 ATO as a lubricant or coating agent for oral solid dosage formulations."( Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals.
Aburahma, MH; Badr-Eldin, SM, 2014
)
0.4
" The results clearly indicate that the physico-chemical properties of the drug and the matrix systems are crucial for the design of ethanol-resistant dosage forms."( Alcohol dose dumping: The influence of ethanol on hot-melt extruded pellets comprising solid lipids.
Feichtinger, A; Jedinger, N; Khinast, J; Mohr, S; Roblegg, E; Schrank, S, 2015
)
0.42
"The aim of this study was to prepare a highly porous multiparticulate dosage form containing cilostazol for gastroretentive drug delivery."( Preparation and optimization of glyceryl behenate-based highly porous pellets containing cilostazol.
Byun, W; Cho, CH; Hwang, KM; Park, ES, 2018
)
0.76
" This study aims at designing a novel dosage form of sustained release taste-masked QT orally disintegrating tablets (ODTs) based on solid lipid micro-pellets (SLMPs)."( A dual strategy to improve psychotic patients' compliance using sustained release quetiapine oral disintegrating tablets.
Boraei, N; Ismail, F; Refaat, A; Sokar, M, 2016
)
0.43
"7 folds compared to the intratracheally dosed YEO solution and by 257-438 folds to the intravenously dosed YEO solution, respectively."( Solid lipid nanoparticles for sustained pulmonary delivery of Yuxingcao essential oil: Preparation, characterization and in vivo evaluation.
Chang, YX; Hu, X; Liao, YH; Liu, CY; Quan, LH; Zhao, Y, 2017
)
0.46
"Antiemetic agent Meclizine HCl, widely prescribed in vertigo, is available only in immediate release dosage forms."( Lipids bearing extruded-spheronized pellets for extended release of poorly soluble antiemetic agent-Meclizine HCl.
Ahmad, M; Ahmed, K; Nasiri, MI; Qazi, F; Shoaib, MH; Yousuf, RI, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (14 Product(s))

Product Categories

Product CategoryProducts
Other2
Beauty & Personal Care7
Vitamins & Supplements3
Professional Supplements2

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
Eucerin Age Defense Lightweight Sunscreen Lotion for Face SPF 50 -- 2.5 fl ozEucerinBeauty & Personal Carecetearyl alcohol, cetyl alcohol, tocopherol, dibutyl adipate, behenyl alcohol, disodium edta, ethylcellulose, ethylhexylglycerin, tocopherol, glycerin, glyceryl behenate, glycyrrhetinic acid, dimethicone, l-carnitine, phenoxyethanol2024-11-29 10:47:42
Jarrow Formulas Alpha Lipoic Sustain With Biotin -- 120 TabletsJarrow FormulasVitamins & SupplementsBiotin, carbomer, glyceryl behenate, microcrystalline cellulose, stearic acid, Alpha-Lipoic Acid, Calcium phosphate2024-11-29 10:47:42
Mineral Fusion Sheer Moisture Lip Tint - Confident -- 0.1 ozMineral FusionBeauty & Personal Carecarmine, CI 75470, tocopherol, tocopherol, glyceryl behenate, limonene, octyldodecanol, titanium dioxide2024-11-29 10:47:42
Mineral Fusion Sheer Moisture Lip Tint - Courageous -- 0.1 ozMineral FusionBeauty & Personal Carecarmine, CI 75470, tocopherol, tocopherol, glyceryl behenate, limonene, octyldodecanol, titanium dioxide2024-11-29 10:47:42
Natrol Melatonin Sleep Fast Dissolve Maximum Strength Citrus -- 10 mg - 60 TabletsNatrolVitamins & Supplementsglyceryl behenate, microcrystalline cellulose, maltodextrin, Melatonin, sucralose2024-11-29 10:47:42
Natrol Melatonin Sleep Tablets Strawberry -- 100 TabletsNatrolVitamins & Supplementsglyceryl behenate, microcrystalline cellulose, maltodextrin, Melatonin, sucralose2024-11-29 10:47:42
The Honest Company Calm & Renew Melting Eye Balm -- 0.5 ozThe Honest CompanyBeauty & Personal Carecitric acid, citric acid, glycerin, glyceryl behenate, linoleic acid, magnesium sulfate, trisodium ethylenediamine disuccinate, phytosterols, propanediol2024-11-29 10:47:42
The Honest Company Extreme Length Mascara + Lash Primer -- 0.07 ozThe Honest CompanyBeauty & Personal Carecaprylyl glycol, cellulose, cetearyl alcohol, cetyl palmitate, tocopherol, ethylhexylglycerin, tocopherol, glyceryl stearate, glycerin, glyceryl behenate, phosphoric acid, sodium benzoate2024-11-29 10:47:42
The Honey Pot Boric Acid & Herbs Suppositories plus Applicator -- 14 SuppositoriesThe Honey PotBeauty & Personal Careboric acid, vitamin E, vitamin E, glyceryl behenate2024-11-29 10:47:42
Vanicream Sunscreen Broad Spectrum SPF 50+ -- 3 ozVanicreamBeauty & Personal Carecaprylyl glycol, glyceryl stearate, glyceryl behenate, propanediol, squalane2024-11-29 10:47:42
Vital Nutrients Hyperbiotics PRO-Dental Probiotic Natural Mint -- 3 billion CFU - 90 Chewable TabletsVital NutrientsProfessional Supplementsdicalcium phosphate, glyceryl behenate, microcrystalline cellulose2024-11-29 10:47:42
Vital Nutrients Hyperbiotics PRO-Dental Probiotic Natural Mint -- 45 Chewable TabletsVital NutrientsProfessional Supplementsdicalcium phosphate, glyceryl behenate, microcrystalline cellulose2024-11-29 10:47:42

Roles (2)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
1-monoglycerideA monoglyceride in which the acyl substituent is located at position 1.
fatty acid esterA carboxylic ester in which the carboxylic acid component can be any fatty acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (156)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (2.56)18.2507
2000's41 (26.28)29.6817
2010's99 (63.46)24.3611
2020's12 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 57.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index57.97 (24.57)
Research Supply Index5.10 (2.92)
Research Growth Index5.20 (4.65)
Search Engine Demand Index93.73 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (57.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (1.88%)5.53%
Reviews2 (1.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other155 (96.88%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]